Objective
The middle ear innate immune response to bacteria leads to acute inflammation consisting of fluid accumulation, infiltration of inflammatory cells, and mucosal thickening. Although inflammation from otitis media generally subsides after 5–7 days, suppression of this response would help alleviate suffering and minimize risk to the inner ear. Glucocorticoids and mineralocorticoids have differential effects on inflammation and fluid absorption, but little is known of their control of middle and inner ear manifestations of acute otitis media. Therefore, steroids were investigated for their potential for therapeutic approaches to control of otitis media.
Design
Both glucocorticoid (prednisolone, dexamethasone) and mineralocorticoid (aldosterone, fludrocortisone) steroids were investigated for their ability to reduce inflammatory symptoms in a mouse otitis media model.
Subjects
Acute inflammation was induced by transtympanic injection of heat killed Streptococcus pneumoniae to 100 Balb/c mice.
Interventions
Twenty mice in each experimental group (prednisolone, dexamethasone, aldosterone, fludrocortisone) were given a steroid in their drinking water the day before inoculation and continued on these treatments until histologic observance. Twenty control mice were treated with water only.
Results
Histologic middle ear morphometrics showed significant steroid effects at both 3 and 5 days in reduction of fluid area, cell number and tympanic membrane thickness.
Conclusions
Glucocorticoids were most effective in controlling inflammation. Interestingly, the mineralocorticoids were also effective in reducing the inflammatory response at 5 days, suggesting their fluid transport function helped clear disease. Thus, steroid control of middle ear disease may be useful in alleviating symptoms faster and reducing risk to the inner ear.